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Abstract 
Background: For the same quantity of cigarettes smoked, relative to more affluent people, 
socioeconomically disadvantaged people have higher levels of smoking biomarkers. This may be 
ascribed to inhaling cigarette smoke more deeply and more frequently and/or choosing higher 
tar-containing brands. We investigated whether this increased tobacco load, as captured using 
cotinine measurements, is associated with a greater risk of mortality in lower social groups. 
Methods: We used Cox proportional hazards models stratified by socioeconomic position to 
calculate hazard ratios in a pooled sample of 15 English and Scottish prospective cohort studies 
(N=81476). 
Results: During a mean (SD) follow-up of 10.3 (4.4) years, 8234 deaths occurred. Risk of total 
mortality (hazard ratio; 95% confidence interval) for smokers relative to never-smokers in the 
high (2.5; 2.1, 3.1), intermediate (2.1; 1.8, 2.4), and low (2.0; 1.9, 2.2) educational groups did not 
differ markedly (p for interaction=0.61). Similar findings emerged when using cause-specific 
outcomes, and occupational social class and housing tenure as socioeconomic indices. 
Conclusion: Contrary to our hypothesis, we found no indication that chronic disease mortality 
associated with smoking was higher in disadvantaged people. 
Keywords: cotinine; smoking; socioeconomic position; cancer; cardiovascular disease; mortality 
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Introduction 
 It is well documented that cigarette smoking is markedly associated with increased risk of 
developing chronic diseases, particularly several cancers and cardiovascular disease (CVD).
1
 It is 
also well known that people in lower socioeconomic groups are much more likely to smoke than 
those from advantaged backgrounds
2—in 2016, for instance, 21% of adults in England without 
formal qualifications smoked, compared with only 9% of those with a university degree.
3
 This 
inequality has increased in recent years—between 2001 and 2012, smoking prevalence decreased 
among those with managerial or professional occupations (from 20% to 14%) while it remained 
unchanged among people in routine and manual occupations in the UK (33%).
4
 Accordingly, the 
population impact of smoking is greater in socioeconomically disadvantaged groups.
2,5
 In 
addition to a greater population prevalence of smoking among people in lower socioeconomic 
groups, there is evidence that, for the same number of cigarettes smoked, less advantaged people 
have higher levels of smoking biomarkers than more advantaged people.
2
 This may be due to the 
manner in which individuals from lower socioeconomic groups smoke—for example by inhaling 
more deeply and more frequently and/or by choosing higher tar-containing brands.
2
 This 
increased tobacco load may lead to a greater risk of mortality—that is, higher smoking-related 
vulnerability—among disadvantaged groups. The few studies that have tested this hypothesis 
have revealed inconsistent findings. For instance, in a large Danish cohort, Nordahl et al. found 
that self-reported smoking carried a greater risk of stroke mortality among lower educated 
groups compared with higher educated groups.
6
 However, in a large Belgian cohort, 
Charafeddine et al. found no evidence of differential vulnerability to self-reported smoking on 
all-cause mortality.
7
 Crucially, studies have exclusively relied on self-reported smoking,
6-8
 which 
is subject to reporting bias, particularly among people with lower education,
9
 and this may 
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generate an inflated hazard in poorer individuals. Thus, we pooled a series of cohort studies with 
cause-specific mortality and measured cotinine data to test the hypothesis that smoking may 
exert a greater influence on health in disadvantaged populations. 
Methods 
Participants originated from the Health Survey for England (HSE) and the Scottish 
Health Survey (SHS), both of which have been described in detail elsewhere.
10,11
 These are 
population-representative, cross-sectional health examination studies conducted in private 
households in England and Scotland. We pooled data from 12 HSE (1994 to 2008), and three 
SHS (1995, 1998, and 2003) studies in which response ranged from 68% to 77%.
10,12
 Following 
participation in these surveys, consenting participants (88%) were linked to National Health 
Service mortality records up to December 2009 (SHS)
12
 and mid-February 2011 (HSE).
10
 
We created a baseline smoking variable by cross-referencing participants’ self-reported 
smoking against their measured salivary or serum cotinine levels (the correlation between 
salivary and cotinine levels is very high)
13
: 1) never smokers were defined by self-reported 
“never smoker” and salivary cotinine below 12 ng/mL or serum cotinine below 9 ng/mL; 2) ex-
smokers self-reported being an “ex-smoker” and had salivary cotinine below 12 ng/mL or serum 
cotinine below 9 ng/mL; and 3) current smokers comprised self-reported smokers and 
individuals with salivary cotinine ≥12 ng/mL, or serum cotinine ≥9 ng/mL. We selected 
endpoints that are known to have a relationship with cigarette smoking:
14
 death from all causes, 
certain cancers (lung, pancreas, esophagus, bladder, kidney, oral, liver, stomach, leukemia), all 
CVD, coronary heart disease (CHD), stroke, and chronic obstructive pulmonary disease (COPD). 
We used three socioeconomic position variables, including: age when finished full-time 
education: high (18 years or above), intermediate (16-17 years), and low (15 years or less); 
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occupational social class based on the UK Registrar’s General categories: high (professional, 
managerial and technical), intermediate (skilled non-manual), and low (manual occupations); and 
housing tenure (owner or renter). As covariates, we included sex, age at baseline (continuous), 
body mass index (weight in kilograms divided by height in meters squared), and dichotomized 
physical activity (any weekly moderate to vigorous exercise) and excessive alcohol intake (as 
≥168 grams/week for men, and ≥112 grams/week for women). 
 We included study members in the analytical sample if they had data on cotinine, self-
reported smoking, socioeconomic variables, covariates (eFigure 1; 
http://links.lww.com/EDE/B412) and if they consented to mortality data linkage. For each 
socioeconomic and smoking group, we calculated age-standardized mortality rates per 10000 
person-years (for five age groups) with the direct method using the 2015 European Standard 
Population as the standard. Subsequently, having ascertained via Schoenfeld residuals that the 
proportional hazards assumption was not violated, we calculated hazard ratios (HR) and 
associated 95% confidence intervals (95% CI) using Cox proportional hazard models. We 
stratified the analysis by socioeconomic position, adjusting the effect estimate first for age, sex, 
and cohort, then additionally for BMI, physical activity, and excessive alcohol intake. We 
imputed missing values for the last three variables using five imputations. Statistical significance 
for multiplicative interaction was assessed using the likelihood ratio test comparing the models 
with and without the product term of smoking and socioeconomic position. We also tested for 
additive interaction by calculating the Relative Excess Risk due to Interaction, the Proportion of 
Disease Attributable to Interaction, and the Synergy Index. In sensitivity analyses, we repeated 
the analysis focusing on premature all-cause and cause-specific mortality and three types of 
smoking exposure (number of cigarettes smoked per day; cotinine level; and self-reported 
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smoking). Analyses were conducted using Stata statistical software version 14 (StataCorp, 
College Station, TX). 
Results 
Our analytical sample comprised 81476 participants with complete data on cotinine, self-
reported smoking, education, age, sex, and mortality (eFigure 1; 
http://links.lww.com/EDE/B412). The mean age of participants at baseline was 46 years (range: 
16 to 97 years), and 53% were women (eTable 1; http://links.lww.com/EDE/B412). During a 
mean (SD) follow-up time of 10.3 (4.4) years, 8234 deaths occurred (1170 from smoking-related 
cancers, 4078 from CVD, 690 from stroke, 1412 from CHD, and 2568 from COPD). The age-
standardized mortality rate was highest among smokers in lower socioeconomic groups. Thus, 
the rate (95% CI) per 10000 person-years for death from all causes was 243 (230, 256) among 
smokers with low education versus 182 (156, 208) among smokers with high education; for 
smoking-related cancer, the corresponding rates were 47 (42, 52) versus 28 (20, 36); and for 
CVD, 110 (102, 118) versus 95 (74, 116) (Figure). Both the basic and multivariable models 
yielded similar findings, thus we present results from the latter only. As anticipated, relative to 
non-smokers, cigarette smoking was related to an elevated risk of death from all causes in the 
high- (HR; 95% CI: 2.5; 2.1, 3.1), intermediate- (2.1; 1.8, 2.4), and low-education group (2.0; 
1.9, 2.2). HRs (95% CI) for smoking-related cancers were 4.4 (3.0, 6.5) in the high-education 
group, 4.4 (3.0, 6.6) in the medium group, and 4.3 (3.5, 5.2) in the low group; and, for CVD, 3.8 
(2.6, 5.5), 2.4 (1.8, 3.2), and 2.5 (2.2, 2.9) (Figure). There was, however, no indication that 
smoking in the more basic educational group was more strongly associated with mortality in 
comparison to the higher educational categories as based on tests for interaction, multiplicative 
or additive (p-values for interaction ≥0.21). We observed similar patterns of association and 
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mortality rates for death from stroke, CHD, and COPD (eFigure 2; 
http://links.lww.com/EDE/B412). Results were also similar when substituting educational level 
for occupational social class (eFigure 3; http://links.lww.com/EDE/B412) and housing tenure 
(eFigure 4; http://links.lww.com/EDE/B412) as the socioeconomic measure of interest. Our 
findings were robust under a range of sensitivity analyses, including three types of smoking 
exposure (eFigure 5-19; http://links.lww.com/EDE/B412). Finally, we found no strong evidence 
of heterogeneity in the association between mortality and smoking across the 15 included cohort 
studies. 
Discussion 
We found no support for the hypothesis of differential vulnerability to the effects of 
smoking on several chronic disease outcomes across different socioeconomic groups. Comparing 
our results to the literature is not straightforward due to differing methodologic approaches, 
different smoking and socioeconomic indicators, and a range of mortality outcomes. However, 
Lewer et al.,
15
 in a similar analysis to ours, also found no evidence of interaction between 
smoking and socioeconomic position on death from all causes and from COPD, while revealing 
higher absolute risk of smoking among more disadvantaged groups. 
Some strengths of our study include the large and representative sample size which 
provided sufficient power to test for interaction, the use of an array of smoking-related chronic 
disease outcomes, and, for the first time to our knowledge, the utilization of an objective 
indicator of smoking exposure. Our work is of course not without its shortcomings. Smoking was 
only measured at baseline and, given the continuous decline of smoking prevalence in the 
population, it is likely that many participants decreased their intake or ceased completely during 
follow-up. 
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In conclusion, in a large and representative series of cohorts of the English and Scottish 
populations, we found no indication of differential association by socioeconomic disadvantage 
between smoking and death from a range of major chronic diseases known to be related to 
tobacco smoking.  
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Figure footnote 
Association between cigarette smoking and death from all causes, smoking-related cancer, and 
CVD, according to educational level, from pooled cohort samples of 12 Health Survey for 
England and 3 Scottish Health Survey studies conducted between 1994 and 2008 (N = 81476). 
Educational level derived from age when finished full-time education: high (18 years or above), 
intermediate (16-17 years), and low (15 years or below). Hazards ratios (95% CI) from Cox 
proportional hazards model are adjusted for age, sex, cohort, body mass index, physical activity 
and excessive alcohol, and are indicated by squares and the 95% confidence interval by the 
horizontal lines. X-axes are natural log-scaled. ASMR: Age-standardized mortality rates 
calculated using the 2015 European Standard Population as the standard. 
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